The Safety and Efficacy of Jobelyn in the Treatment of Breast Cancer Patients
Haematological Abnormality
About this trial
This is an interventional treatment trial for Haematological Abnormality focused on measuring Breast Cancer, Jobelyn, Sorghum bicolor
Eligibility Criteria
Inclusion Criteria:
Women with histologically confirmed breast cancer who had undergone complete or segmental mastectomy plus axillary node dissection were included
Exclusion Criteria:
Patients were excluded if they had distant metastases residual disease in the breast or axilla other serious medical illnesses, or a previous cancer. Women considering pregnancy or using hormones were excluded
Patients who refuse to sign consent form
Sites / Locations
- Lagos State University Teaching HospitalRecruiting
- Lagos State UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Jobelyn + Cyclophosphamide-Epirubicin6
Placebo + Cyclophosphamide- Epirubicin 6
Cyclophosphamide- Epirubicin 6 course regimen to be used with Jobelyn
Routine drugs for treatment of Breast Cancer used with Placebo